TAMPA, Fla. — Moffitt Cancer Center has named Shelley Tworoger, PhD, its new Associate Center Director of Population Science. Tworoger's research focuses on enhancing ovarian cancer prevention and improving understanding of breast and ovarian carcinogenesis through collaborations with biostatisticians, pathologists and oncologists.
Prior to joining the Moffitt team, Tworoger was Associate Professor of Medicine at Harvard Medical School, Associate Professor of Epidemiology at Harvard's T.H. Chan School of Public Health, and Faculty Director of the Brigham and Women's Hospital/Harvard Cohorts Biorepository. She also served as Associate Director of the Harvard Nurses' Health Study, one of the largest investigations into the risk factors for major chronic diseases in women. Since 2009, Dr. Tworoger has co-chaired the steering committee of the Ovarian Cancer Cohort Consortium (OC3), an international, National Cancer Institute-sponsored research effort.
About Moffitt Cancer Center
Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only 49 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s excellence in research, clinical trials, prevention and cancer control. Moffitt is a Top 10 cancer hospital and has been nationally ranked by U.S. News & World Report since 1999. Moffitt’s expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet® status, its highest distinction. With more than 5,700 team members, Moffitt has an economic impact in the state of $2.1 billion. For more information, call 1-888-MOFFITT (1-888-663-3488), visit MOFFITT.org, and follow the momentum on Facebook, Twitter and YouTube.